Notice of Authorisation for Expanding Import, Supply and Distribution Under the COVID-19 Public Health Response (Point-of-care Tests) Order 2021
Pursuant to clause 8 of the COVID-19 Public Health Response (Point-of-care Tests) Order 2021 (“Order”), I, the Director-General of Health, hereby authorise the following persons or class of persons:
The authorised persons or class of persons are:
to import, supply, distribute, sell to other authorised persons or classes of persons, and use (excluding the importation or supply for any individual’s personal use) the following point-of-care tests:
Product Name | Manufacturer | Configuration |
SARS-CoV-2 Rapid Antigen Test (SD Biosensor) (Nasal, Nasopharyngeal, or Oropharyngeal swab) | SD Biosensor (South Korea) | Professional or self-test of any package size |
PanBio COVID-19 Ag Rapid (Nasal, Nasopharyngeal, or Oropharyngeal swab) | Abbott Rapid Diagnostics Jena GmbH (Germany) | Professional or self-test of any package size |
CareStart COVID-19 Antigen (Nasal, Nasopharyngeal, or Oropharyngeal swab) | Access Bio Inc (United States of America) | Professional or self-test of any package size |
CLINITEST® Rapid COVID-19 Antigen Test (Nasal, Nasopharyngeal, or Oropharyngeal swab) | Healgen Scientific Limited Liability Company (United States of America) | Professional or self-test of any package size |
Orient Gene Rapid COVID-19 (Antigen) Test (Nasal, Nasopharyngeal, or Oropharyngeal swab) | Zhejiang Orient Gene Biotech Co., Ltd (China) | Professional or self-test of any package size |
Atomo COVID-19 Antigen Test (Nasal, Nasopharyngeal, or Oropharyngeal swab) | Access Bio Inc (United States of America) | Professional or self-test of any package size |
Dated at Wellington this 20th day of January 2022.
Dr ASHLEY BLOOMFIELD, Director-General of Health, Ministry of Health.